u/Responsible-Quote717

I really hope Rennie and the coaching team try something different with this team this week.

I'd rather see us take some risks with selections, try different combinations, experiment a little with the tactics, and lose by 20, than try the same thing again and lose by 3.

Obviously we want to win every game if we can, but I don't think doing the same thing again this week is going to give us the best chance.

Taylor out. Parker or Jacobson out (or both). Vaa'i back to 6 with a new locking combo? Blackadder in. Tavatavanawai in. Narawa in. Maybe Rieko? As incredible as he is, Jordan looks like he needs a rest (maybe just a shorter shift?)

Could even try out a new fullback/fly half combo... not sure if Mounga is the answer, but could be worth a go. Love to the back with Mounga at 10? Mackenzie to come off the bench? J Barrett at fullback and Ioane at 13 with Tupaea at 12, or Big Jim at 12 and Tupaea still 13? Then move Barrett in to 12 with Mackenzie coming off the bench?

Definitely need better use of the bench, no matter what the selections are.

Just spitblling here, but we have so many interesting options that could surprise the Boks. I hope we aren't too conservative.

I don't know.

Over a million shares purchased at a higher price than the stock is at currently.

Love to see it.

https://www.gurufocus.com/news/9046732/driehaus-capital-management-llc-expands-definium-therapeutics-inc-dftx-stake

"Now, the biotech—formerly known as MindMed—plans to share anxiety data this week, findings that could push Definium’s stock up “25-50% or more,” Jefferies analysts wrote in a Thursday note."

🤑🚀

With the GAD results due this week, I assume we're all expecting similar results to what we got with the Phase 2b trial and the MDD results from June.

But, how priced-in do you think these results are already? What sort of price movement are we expecting after the results drop? Any guesses?

Good luck and Godspeed. 🚀

Most of the research on LSD focuses on the experience itself: what people see, feel, and think while the drug is active. The hours during the trip are treated as the event. What comes after is treated as the aftermath, a return to normal.

A new study from the University of Fribourg asked a different question. Instead of measuring what LSD does while people are on it, researchers waited. They gave 45 healthy adults a full clinical dose and sent them home. They did not test them that day.

One week later, participants came back. The researchers measured their stress levels using validated psychological scales. They measured their ability to generate alternative solutions to difficult problems, a core component of cognitive flexibility. They ran motor learning tests. They took brain measurements.

What they found in that one-week window was not what most people would expect from a drug that had finished working six days earlier.

There's been a lot of comments about profit selling, but who out there is buying at the moment?

If you're planning on buying more in the future, what sort of pullback are you looking for as an entry point?

So, are we all thinking that June 11th is the date we get out first Phase III results announcement?

Is this the week we've been waiting for for years?

Will we be above $30 by weeks end?

How are we all feeling?